MASTERINVEST Kapitalanlage GmbH Grows Stake in UnitedHealth Group Incorporated $UNH

MASTERINVEST Kapitalanlage GmbH increased its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 22.2% during the second quarter, Holdings Channel reports. The firm owned 13,927 shares of the healthcare conglomerate’s stock after acquiring an additional 2,527 shares during the quarter. MASTERINVEST Kapitalanlage GmbH’s holdings in UnitedHealth Group were worth $5,788,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Jacobs Equity LLC boosted its position in shares of UnitedHealth Group by 22.6% during the second quarter. Jacobs Equity LLC now owns 2,443 shares of the healthcare conglomerate’s stock worth $1,015,000 after acquiring an additional 450 shares during the last quarter. Proficio Capital Partners LLC purchased a new stake in UnitedHealth Group in the 2nd quarter worth $1,973,000. Transamerica Financial Advisors LLC grew its position in shares of UnitedHealth Group by 2.7% during the second quarter. Transamerica Financial Advisors LLC now owns 6,539 shares of the healthcare conglomerate’s stock valued at $2,718,000 after purchasing an additional 175 shares in the last quarter. Corient Private Wealth LP bought a new stake in shares of UnitedHealth Group in the second quarter worth about $245,516,000. Finally, Perennial Investment Advisors LLC boosted its stake in UnitedHealth Group by 7.3% during the second quarter. Perennial Investment Advisors LLC now owns 2,710 shares of the healthcare conglomerate’s stock valued at $1,126,000 after buying an additional 184 shares during the last quarter. Hedge funds and other institutional investors own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on UNH shares. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of UnitedHealth Group in a report on Thursday, June 11th. Morgan Stanley boosted their price target on shares of UnitedHealth Group from $468.00 to $529.00 and gave the stock an “overweight” rating in a research report on Friday, July 17th. Leerink Partners increased their price objective on shares of UnitedHealth Group from $400.00 to $462.00 and gave the company an “outperform” rating in a research report on Wednesday, June 17th. Sanford C. Bernstein restated an “outperform” rating on shares of UnitedHealth Group in a report on Tuesday, July 21st. Finally, Wells Fargo & Company lifted their price target on UnitedHealth Group from $397.00 to $485.00 and gave the stock an “overweight” rating in a research report on Monday, July 13th. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and six have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $456.56.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 1,169 shares of the firm’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total transaction of $455,910.00. Following the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at approximately $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Company insiders own 0.19% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE:UNH opened at $394.57 on Friday. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The firm has a market cap of $354.17 billion, a PE ratio of 25.39, a price-to-earnings-growth ratio of 1.39 and a beta of 0.62. The firm’s 50 day simple moving average is $413.42 and its 200-day simple moving average is $359.88. UnitedHealth Group Incorporated has a one year low of $255.96 and a one year high of $461.62.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share (EPS) for the quarter, topping the consensus estimate of $4.94 by $1.44. The company had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.UnitedHealth Group’s revenue was up .4% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $4.08 earnings per share. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 19.82 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Investors of record on Monday, September 14th will be issued a $2.32 dividend. This represents a $9.28 annualized dividend and a dividend yield of 2.4%. The ex-dividend date is Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

UnitedHealth Group Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.